ArticleSurgical endoscopy2025
Surgical management of marginal ulcer sequelae after Roux-en-Y gastric bypass: a single-center retrospective cohort study.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMarginal ulcer (MU) is a rare complication following Roux-en-Y Gastric Bypass (RYGB). If left untreated, MU can progress into severe sequelae, including ulcer stenosis, gastrogastric fistula (GGF), or perforation. The aim of this study is to describe the surgical management for each of the three types of MU sequelae and to evaluate the risk of ulcer recurrence and the impact on weight loss following Revisional Bariatric Surgery (RBS).
methodsA retrospective analysis of patients who underwent RBS for MU sequelae between October 2008 and October 2024 was conducted. Patients' demographics, perioperative outcomes, weight loss, and ulcer recurrence were compared between the three types of MU sequelae.
resultsSixty-six patients were included. Thirty-nine percent had ulcer stenosis, 30.3% had GGF, and 30.3% had perforation. The mean time in years from RYGB to the RBS was 6.9 years for patients with stenosis, 17.5 years for those with GGF, and 5.3 years for those with perforation. Epigastric pain, nausea, and vomiting were common, and PO intolerance was mainly seen in ulcer stenosis. Operative time varied significantly, with the GGF group having the longest duration (p = 0.001). This group also showed higher rates of Clavien-Dindo grade ≥ 3 complications and reinterventions (p = 0.01). Five-year follow-up showed that patients with GGF had the greatest percentage of total weight loss (p = 0.007), while patients with ulcer stenosis experienced weight regain during the first two years and slight weight regain at the later follow-up. The overall ulcer recurrence was 32.4%, with no significant differences observed in recurrence rates among them (p = 0.98).
conclusionManaging MU after RYGB requires comprehensive diagnosis, including upper GI endoscopy, swallow study, and abdominal CT, to assess anatomical abnormalities. While surgery is effective, the recurrence of ulcers remains a risk. Patients with stenosis often regain weight after redo gastrojejunostomy, whereas those with GGF tended to lose weight after RBS.
Indexed as
Identifiers
40897876What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.